文献速递妇科产科

降低风险输卵管卵巢切除术后腹膜癌风险:突变状态与STIC病变的影响

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.
PubMed 文献 · Gynecol Oncol · 2026-03-11

法国多中心回顾性研究纳入1351例卵巢癌高风险女性(984例携带BRCA1/2致病突变),随访7433.3人年。RRSO时14例检出STIC,随访中4例发生腹膜癌,总体5年累积发病率0.4%,BRCA1/2携带者为0.5%;RRSO时伴STIC者5年腹膜癌风险达11.1%。

要点

  • RRSO时检出STIC者5年腹膜癌风险为11.1%,需个体化随访。
  • BRCA1/2携带者RRSO后5年腹膜癌累积发病率为0.5%。
  • 手术年龄与病理发现相关:浸润癌中位55岁、STIC 54岁、良性病变51岁。

核心结论

  • 在高遗传风险女性中强调早期RRSO、细致输卵管评估及术后延长监测。
  • RRSO时检出STIC提示需定制化随访策略。

研究设计与样本

  • 法国多中心双向性(ambispective)研究,纳入1351例卵巢癌高风险女性,其中984例携带BRCA1/2致病突变。
  • 随访总计7433.3人年,记录RRSO后腹膜癌发生率,并对RRSO标本复核以识别STIC。

主要发现

  • RRSO时14例检出STIC,其中10例为BRCA1携带者、2例为BRCA2携带者。
  • 随访期间4例发生腹膜癌,总体队列5年累积发病率为0.4%,BRCA1/2携带者为0.5%。
  • 手术年龄与病理发现显著相关:浸润癌中位年龄55岁、STIC 54岁、良性病变51岁(p < 0.001)。
  • RRSO时伴STIC的女性5年腹膜癌风险为11.1%。

关键数值与推荐

  • 现行指南推荐BRCA1携带者在35至40岁、BRCA2携带者在40至45岁行RRSO。
  • RRSO时检出STIC者5年腹膜癌风险为11.1%。

临床怎么用

  • 对BRCA1/2携带者等高遗传风险女性按指南推荐年龄行RRSO。
  • RRSO手术标本应细致评估输卵管以识别STIC。
  • RRSO后需延长腹膜癌监测,检出STIC者应定制化随访。

局限性

  • 需进一步研究评估分期手术或定期监测(CA125或ctDNA等创新标志物)的有效性与并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women with inherited susceptibility or a strong family history of ovarian cancer, particularly carriers of pathogenic BRCA1/2 variants, face a markedly increased lifetime risk. To mitigate this risk, current guidelines recommend risk-reducing salpingo-oophorectomy (RRSO) between ages 35 and 40 for BRCA1 and between ages 40 and 45 for BRCA2 METHODS: We conducted an ambispective multicenter study in France including 1351 women at high risk of ovarian cancer, 984 of whom carried BRCA1/2 pathogenic variants, totaling 7433.3 woman-years of follow-up. When histological reports from RRSO revealed abnormalities, surgical specimens were reviewed, with special focus on the fallopian tubes to identify serous tubal intraepithelial carcinoma (STIC). The incidence of peritoneal carcinoma (PC) after RRSO was recorded. RESULTS: STIC was detected in 14 patients at RRSO (10 BRCA1; 2 BRCA2 carriers). During follow-up, 4 women developed PC, corresponding to a 5-years cumulative incidence of 0.4% in the overall cohort and 0.5% among BRCA1/2 carriers. Age at surgery was significantly associated with pathological findings: invasive carcinoma was detected at a median age of 55 years, STIC at 54 years, and benign lesions at 51 years (p < 0.001). Notably, women with STIC at RRSO had a 5-year PC risk of 11.1%. CONCLUSIONS: These findings highlight the importance of early RRSO, meticulous tubal evaluation, and extended post-surgical surveillance in genetically at-risk women. Detection of STIC warrants tailored follow-up strategies. Further studies are needed to assess the effectiveness and morbidity of staging surgery or regular monitoring using CA125 or innovative markers such as ctDNA.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Saule C, Laas E, Weber N, et al. Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions. Gynecol Oncol. 2026. PMID: 41818853. doi:10.1016/j.ygyno.2026.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。